Guardant Health director plans $20,300 share sale

Guardant Health director Musa Tariq filed a Rule 144 notice to sell 116 shares of GH common stock from equity compensation.

Rhea-AI Filing Summary

Guardant Health, Inc. (GH) director Musa Tariq filed a notice of proposed sale under Rule 144 for 116 shares of common stock, to be sold through Charles Schwab & Co., Inc. The shares have an aggregate market value of $20,300, with Guardant Health reporting 134,196,170 shares outstanding as of September 16, 2026.

The 116 shares derive from equity compensation following a restricted stock lapse dated August 15, 2026. Over the prior three months, Tariq reported multiple sales of Guardant Health common stock totaling several hundred thousand dollars in aggregate proceeds.

Key Figures

Shares proposed for sale: 116 shares Aggregate market value of proposed sale: $20,300 Shares outstanding: 134,196,170 shares +4 more

7 metrics

Shares proposed for sale 116 shares Common stock under Rule 144 notice by director Musa Tariq

Aggregate market value of proposed sale $20,300 Value of 116 Guardant Health common shares covered by the notice

Shares outstanding 134,196,170 shares Guardant Health common stock outstanding as of September 16, 2026

Sale on June 16, 2026 116 shares for $15,102 Guardant Health common stock sold by Musa Tariq in prior 3 months

Sale on June 22, 2026 1,951 shares for $255,893 Guardant Health common stock sold by Musa Tariq in prior 3 months

Sale on July 16, 2026 116 shares for $18,941 Guardant Health common stock sold by Musa Tariq in prior 3 months

Sale on August 17, 2026 116 shares for $18,148 Guardant Health common stock sold by Musa Tariq in prior 3 months

Key Terms

Rule 144, Restricted Stock Lapse, Equity Compensation

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Lapse financial

"Common | 08/15/2026 | Restricted Stock Lapse | Guardant Health, Inc."

Equity Compensation financial

"116 | 08/15/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health (GH) director Musa Tariq plan to sell under this Form 144?

Musa Tariq filed to potentially sell 116 shares of Guardant Health common stock under Rule 144. The proposed sale is through Charles Schwab & Co., Inc. and relates to shares acquired as equity compensation after a restricted stock lapse on August 15, 2026.

What is the estimated market value of the Guardant Health (GH) shares in this Form 144?

The filing lists an aggregate market value of $20,300 for the 116 Guardant Health common shares covered by the notice. This amount reflects the value at the time of the filing for the proposed Rule 144 sale.

How many Guardant Health (GH) shares were outstanding as of the Form 144 date?

Guardant Health reported 134,196,170 shares of common stock outstanding as of September 16, 2026. This figure provides context for the relative size of the 116-share proposed sale under Rule 144.

What prior Guardant Health (GH) stock sales by Musa Tariq are disclosed in this Form 144?

The notice lists sales on June 16, 2026 for 116 shares at $15,102, June 22, 2026 for 1,951 shares at $255,893, July 16, 2026 for 116 shares at $18,941, and August 17, 2026 for 116 shares at $18,148.

What is the source of the Guardant Health (GH) shares being sold by Musa Tariq?

The 116 shares covered by the notice were acquired as equity compensation from a restricted stock lapse dated August 15, 2026. The Form 144 identifies this as the nature of acquisition for the securities to be sold.

Through which broker will the Guardant Health (GH) shares be sold under this Form 144?

The filing identifies Charles Schwab & Co., Inc. as the broker for the proposed sale of 116 Guardant Health common shares. The broker’s listed location is 3000 Schwab Way, Westlake, Texas 76262.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:03 PM Accepted by SEC EDGAR 09/16/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Tariq Musa
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	20300.00	134196170	09/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			116	08/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/16/2026	116	15102.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/22/2026	1951	255893.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	07/16/2026	116	18941.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	08/17/2026	116	18148.00

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Musa Tariq
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)